Recursion Pharmaceuticals Inc (RXRX) EV/EBITDA Multiple

Public company logo of Recursion (RXRX)

Recursion Pharmaceuticals (RXRX) is facing a liquidity shortage due to massive IT infrastructure expenditures. The EV/EBITDA ratio of this capital-intensive business reflects this volatility, with the metric currently standing at 0.00. The company attracts top specialists by synthesizing biology and neural networks for drug discovery, while outsourcing cloud computing and clinical trials to external contractors.

RXRX Recursion Pharmaceuticals: Company Value to EBITDA in the range 11/23/2025 - 11/10/2026
Manufactured products of Recursion Pharmaceuticals Inc

The Recursion Pharmaceuticals (RXRX) AI ecosystem transforms drug discovery into a high-tech machine learning cycle that requires significant capital expenditures. Analyzing the Enterprise Value to EBITDA multiple, which combines market capitalization and net debt, allows for an assessment of the business's real value relative to its ability to generate cash flow, determining the asset's fundamental stability under debt load.

Key competitors

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nvidia Corp NVDA|Total Company Value to Operating Income Before Depreciation Ratio CoreWeave Corp (CRWV)|Nebius - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio soundhound.com SOUN|Zeta Global Corp (ZETA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Pagaya Technologies Ltd. (PGY)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization C3 AI|Enterprise Value to Operating Income Before Depreciation RZLV (Rezolve)|Enterprise Value to EBITDA Ratio SUPX (Super X AI Technology Ltd)|DNA (Ginkgo Bioworks Holdings, Inc.) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cerence CRNC|PDYN (Palladyne AI Corp) - Company Value to Operating Income Before Depreciation Ratio|Veritone Corp - EV/EBITDA Multiple|Business Value to Operating Income Before Depreciation MIMI (Mint Incorporation)|MLGO: EV/EBITDA Multiple|Helport AI (HPAI) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization LivePerson|QUIK: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization System1, Inc. (SST)|Enterprise Value to EBITDA Ratio WiSA Technologies, Inc. DVLT|EV/EBITDA Multiple RYET (Ruanyun Edai Technology)|EV/EBITDA Multiple wetourvip.com WETO|Micropolis - EV/EBITDA Multiple|Cyngn Inc. (CYN) - Enterprise Value to EBITDA Ratio|YYAI: EV/EBITDA Multiple|Company Value to EBITDA MicroCloud Hologram Inc. (HOLO)|Enterprise Value to EBITDA Ratio MSAI|EV/EBITDA Multiple evaxion-biotech.com|Enterprise Value to EBITDA Ratio AIXI (Xiao-I Corporation)|Enterprise Value to Operating Income Before Depreciation Ratio CXAI|EV/EBITDA Multiple BNAI (Brand Engagement Network Inc.)|Total Company Value to Operating Income Before Depreciation Ratio Gaxos.ai Inc (GXAI)|Evogene, Ltd. - EV/EBITDA Multiple|Infobird Co., Ltd (IFBD) - Enterprise Value to EBITDA Ratio|TAOP: EV/EBITDA Multiple|VERSES AI (VSAI) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Exscientia PLC|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization FOXO|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vocodia Holdings Corp. (VHAI)|Total Company Value to Operating Income Before Depreciation Ratio zapata.ai